Literature DB >> 316433

Cultivation of Pneumocystis carinii with WI-38 cells.

M S Bartlett, P A Verbanac, J W Smith.   

Abstract

Pneumocystis carinii has been successfully cultured with WI-38 human embryonic lung fibroblasts. Inoculum was obtained from infected lungs of cortisone-treated Sprague-Dawley rats. Trophozoites reached peak numbers between days 4 and 8 and grew in two subcultures, but then proliferation ceased. If primary cultures were harvested and new medium were added, a second and sometimes a third harvest could be obtained. Cell monolayers were not destroyed. After growth of the initial inoculum had ceased, monolayers supported growth of a new inoculum. Harvested organisms had few contaminating tissue culture cells. Additional studies of growth requirements are needed. Although cultures cannot be used to diagnose P. carinii infection, cultured organisms should be useful for studies of biology and pathogenesis and for the development of immunodiagnostic techniques.

Entities:  

Mesh:

Year:  1979        PMID: 316433      PMCID: PMC273273          DOI: 10.1128/jcm.10.6.796-799.1979

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  4 in total

1.  Latent Pneumocystis infection of rats, relapse, and chemotherapy.

Authors:  J K Frenkel; J T Good; J A Shultz
Journal:  Lab Invest       Date:  1966-10       Impact factor: 5.662

2.  Propagation of Pneumocystis carinii in vitro.

Authors:  L L Pifer; W T Hughes; M J Murphy
Journal:  Pediatr Res       Date:  1977-04       Impact factor: 3.756

3.  Serial propagation of Pneumocystis carinii in cell line cultures.

Authors:  C R Latorre; A J Sulzer; L G Norman
Journal:  Appl Environ Microbiol       Date:  1977-05       Impact factor: 4.792

4.  Pneumocystis carinii in vitro: A study by scanning electron microscopy.

Authors:  M J Murphy; L L Pifer; W T Hughes
Journal:  Am J Pathol       Date:  1977-02       Impact factor: 4.307

  4 in total
  44 in total

1.  Models for evaluating compounds for activity against Pneumocystis carinii.

Authors:  M S Bartlett
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-03       Impact factor: 3.267

Review 2.  Pneumocystis carinii, an opportunist in immunocompromised patients.

Authors:  M S Bartlett; J W Smith
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

3.  Role of fibronectin in Pneumocystis carinii attachment to cultured lung cells.

Authors:  S T Pottratz; W J Martin
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

4.  Pneumocystis carinii induces an oxidative burst in alveolar macrophages.

Authors:  H A Hidalgo; R J Helmke; V F German; J A Mangos
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

5.  Techniques for examining Pneumocystis carinii in fresh specimens.

Authors:  J J Ruffolo; M T Cushion; P D Walzer
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

6.  Activity of clindamycin with primaquine against Pneumocystis carinii in vitro and in vivo.

Authors:  S F Queener; M S Bartlett; J D Richardson; M M Durkin; M A Jay; J W Smith
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

7.  New rat model of Pneumocystis carinii infection.

Authors:  M S Bartlett; J A Fishman; S F Queener; M M Durkin; M A Jay; J W Smith
Journal:  J Clin Microbiol       Date:  1988-06       Impact factor: 5.948

8.  Pneumocystis carinii attachment increases expression of fibronectin-binding integrins on cultured lung cells.

Authors:  S T Pottratz; A L Weir; P E Wisniowski
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

9.  Close association of Pneumocystis carinii from infected rat lung with culture cells as shown by light and electron microscopy.

Authors:  M S Bartlett; M P Goheen; C H Lee; M M Shaw; M M Durkin; J W Smith
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

10.  Pneumocystis carinii: inhibition of lung cell growth mediated by parasite attachment.

Authors:  A H Limper; W J Martin
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.